Content area
Full text
Prenatal blood test developer Cradle Genomics has secured $17.1 million to help build out its laboratory operations, as well as kick off clinical testing of its methods for fetal genetic testing and pregnancy health screening within the first trimester.
The San Diego-based company’s series A round was led by Illumina Ventures and the VC fund Section 32, headed up by former Calico and Google Ventures founder Bill Maris. Other backers...